Report overview
Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.
This report aims to provide a comprehensive presentation of the global market for Nonalcoholic Steatohepatitis (NASH), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonalcoholic Steatohepatitis (NASH). This report contains market size and forecasts of Nonalcoholic Steatohepatitis (NASH) in global, including the following market information:
Global Nonalcoholic Steatohepatitis (NASH) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Nonalcoholic Steatohepatitis (NASH) market was valued at US$ 3152.9 million in 2022 and is projected to reach US$ 41860 million by 2029, at a CAGR of 44.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
NASH is projected to lead the cause of liver transplantation in the U.S. in the coming years. Some major factors such as higher prevalence of NASH, expected launch of pipeline drugs, and higher number of unmet needs drive the growth of this market. However, poor diagnosis of NASH due to the lack of ideal diagnostic technologies limit the growth of the NASH market.
We surveyed the Nonalcoholic Steatohepatitis (NASH) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonalcoholic Steatohepatitis (NASH) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Nonalcoholic Steatohepatitis (NASH) Market Segment Percentages, by Type, 2022 (%)
Obeticholic acid?OCA?
Selonsertib
Global Nonalcoholic Steatohepatitis (NASH) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Nonalcoholic Steatohepatitis (NASH) Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Online Provider
Retail Pharmacy
Global Nonalcoholic Steatohepatitis (NASH) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Nonalcoholic Steatohepatitis (NASH) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nonalcoholic Steatohepatitis (NASH) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nonalcoholic Steatohepatitis (NASH) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nonalcoholic Steatohepatitis (NASH), market overview.
Chapter 2: Global Nonalcoholic Steatohepatitis (NASH) market size in revenue.
Chapter 3: Detailed analysis of Nonalcoholic Steatohepatitis (NASH) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nonalcoholic Steatohepatitis (NASH) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
